Held, Thomas
Franke, Henrik
Lang, Kristin
Eichkorn, Tanja
Regnery, Sebastian
Weusthof, Katharina
Bauer, Lukas
Plath, Karim
Dyckhoff, Gerhard
Plinkert, Peter K.
Harrabi, Semi B.
Herfarth, Klaus
Debus, Jürgen
Adeberg, Sebastian
Funding for this research was provided by:
Medizinische Fakultät Heidelberg der Universität Heidelberg
Article History
Received: 28 January 2022
Accepted: 12 October 2022
First Online: 5 December 2022
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Heidelberg University (S-421/2015). Patients received treatment at our institution after informed consent.
: Not applicable.
: T.E. received travel reimbursement from Bristol-Myers Squibb outside the submitted work. J.D. reports grants from CRI The Clinical Research Institute, grants from View Ray Inc., grants from Accuray International, grants from Accuray Incorporated, grants from RaySearch Laboratories AB, grants from Vision RT limited, grants from Merck Serono GmbH, grants from Astellas Pharma GmbH, grants from Astra Zeneca GmbH, grants from Siemens Healthcare GmbH, grants from Solution Akademie GmbH, grants from Eromed PLC Surrey Research Park, grants from Quintiles GmbH, grants from Pharmaceutical Research Associates GmbH, grants from Boehringer Ingelheim Pharma GmbH Co, grants from PTW-Frieburg Dr. Pychlau GmbH, grants from Nanobiotix A.a., outside the submitted work. The other authors declare no conflict of interest. S.A. reports grants from Novocure Inc., Accuray International Sàrl, Merck Sharp&Dohme, Sanofi-Aventis GmbH and Merk Serono GmbH outside the submitted work.